High Granular Tick Data API: US Stocks Learn more

MAAT PHARMA S.A. EO-1 (4RD F) stock market data APIs

€4.1914 -0.22(-5.2%)
as of December 22, 2025
Try our APIs with free plan!

MAAT PHARMA S.A. EO-1 Financial Data Overview

Price chart is built with Anychart
ISIN: FR001263**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

MaaT Pharma SA, a late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival. Its products pipeline includes MaaT013, that is in pivotal phase 3 clinical trial for the treatment of acute graft versus host diseases with gastrointestinal involvement; MaaT033, which is in phase 2b clinical trial for the improvement of survival at 12 months for patients with blood cancer receiving allogenic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors, as well as MaaT034 that optimize immune checkpoint inhibitor treatment. The company was incorporated in 2014 and is headquartered in Lyon, France.

Prev. Close 4.1914
Open 3.9672
High 4.1968
Low 3.7877
52 wk Range 3.46-8.82
Market Cap 80 158 K
Shares Outstanding 18 752 K
Revenue 3 922 K
Beta -0.073

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get MAAT PHARMA S.A. EO-1 data using free add-ons & libraries


Get MAAT PHARMA S.A. EO-1 Fundamental Data

MAAT PHARMA S.A. EO-1 Fundamental data includes:

  • Net Revenue: 3 922 K
  • EBITDA: -30 214 000
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get MAAT PHARMA S.A. EO-1 Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: NaN
  • EPS/Forecast: NaN
GET THE PACKAGE

Get MAAT PHARMA S.A. EO-1 End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat

Send the request

Leave your email and our team will contact you ASAP.